References
- Pan American Health Organization. Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings. World Health Organization. 2013. p. 1–53.
- Burroughs G, Connor T, McDiarmid M. NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. National Institute for Occupational Safety and Health (NIOSH) Inst Occup. 2004;58:1–40.
- Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin. 2006;56(6):354–365. doi:10.3322/canjclin.56.6.354.
- Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm. 2018;75(24):1996–2031. doi:10.2146/ajhp180564.
- Ocran Mattila P, Ahmad R, Hasan SS, Babar ZUD. Availability, affordability, access, and pricing of anti-cancer medicines in low- and middle-income countries: a systematic review of literature. Front Public Health. 2021;9:678744.
- Asefa S, Aga F, Dinegde NG, Demie TG. Knowledge and practices on the safe handling of cytotoxic drugs among oncology nurses working at tertiary teaching hospitals in Addis Ababa, ethiopia. Drug Healthc Patient Saf. 2021;13:71–80. doi:10.2147/DHPS.S289025.
- Buser JM. The Need for Hematology Nurse Education in Low- and Middle-Income Countries: A Community Case Study in Tanzania. Front Public Health. 2017;5:65.
- von Grünigen S, Geissbühler A, Bonnabry P. The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices. J Oncol Pharm Pract. 2022;28(2):410–420. doi:10.1177/1078155221995539.
- von Grünigen S, Geissbühler A, Bonnabry P. Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries. J Oncol Pharm Pract. 2021;27(6):1422–1431. doi:10.1177/1078155220956687.
- Smith M, Ashenef A, Lieberman M. Paper analytic device to detect the presence of four chemotherapy drugs. J Glob Oncol. 2018;4:1–10. doi:10.1200/JGO.18.00198.
- Osinde G, Niyonzima N, Mulema V, et al. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda. Future Oncol. 2021;17(21):2735–2745. doi:10.2217/fon-2021-0117.
- Martei YM, Chiyapo S, Grover S, et al. Availability of WHO essential medicines for cancer treatment in Botswana. J Glob Oncol. 2018;4:1–8. doi:10.1200/JGO.17.00063.
- World population review. Ethiopia’s population by 2022. Available from: https://worldpopulationreview.com/countries/ethiopia-population. Accessed 23 May 2022.
- Jaspal R. Content analysis, thematic analysis and discourse analysis. Research methods in psychology. 2020 Jan;1:285–312.
- Ethiopian Federal Ministry of Health. National Cancer Control Plan 2016 - 2020. Dis Prev Control Dir. 2015; 1–83.
- Kasahun GG, Gebretekle GB, Hailemichael Y, Woldemariam AA, Fenta TG. Catastrophic healthcare expenditure and coping strategies among patients attending cancer treatment services in Addis Ababa, Ethiopia. BMC Public Health. 2020;20(1):1–10. doi:10.1186/s12889-020-09137-y.
- Yifru S, Muluye D. Childhood cancer in Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2015;8:474. doi:10.1186/s13104-015-1440-1.
- Bernabeu-Martínez MA, Ramos Merino M, Santos Gago JM, Álvarez Sabucedo LM, Wanden-Berghe C, Sanz-Valero J. Guidelines for safe handling of hazardous drugs: A systematic review. PLoS One. 2018;13(5):e0197172. doi:10.1371/journal.pone.0197172.
- Haileselassie W, Mulugeta T, Tigeneh W, Kaba M, Labisso WL. The situation of cancer treatment in Ethiopia : challenges and opportunities. J Cancer Prev. 2019;24(1):33–42. doi:10.15430/JCP.2019.24.1.33.